Scarica l'app Stockscreener
9.345
3.36%
-0.325
Pre-mercato:
9.56
0.215
+2.30%
Precedente Chiudi:
$9.67
Aprire:
$9.59
Volume 24 ore:
330.89K
Relative Volume:
1.21
Capitalizzazione di mercato:
$205.62M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-9.9415
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+3.95%
1M Prestazione:
+32.18%
6M Prestazione:
+120.92%
1 anno Prestazione:
+226.75%
Intervallo 1D:
$8.905
$9.75
Intervallo di 1 settimana:
$8.835
$9.75
Portata 52W:
$2.38
$9.75
Exagen Inc Stock (XGN) Company Profile
Nome
Exagen Inc
Settore
Industria
Telefono
(760) 560-1501
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Confronta XGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
9.345 | 212.78M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
485.04 | 183.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.22 | 149.76B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
653.95 | 53.12B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.87 | 34.17B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
189.40 | 32.34B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Iniziato | Craig Hallum | Buy |
| 2022-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-04-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cowen | Outperform |
| 2019-10-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Exagen Inc Borsa (XGN) Ultime notizie
Why Exagen Inc. stock attracts strong analyst attentionJuly 2025 Setups & High Conviction Investment Ideas - Newser
What risks could impact Exagen Inc. stock performanceStop Loss & Short-Term High Return Strategies - Newser
Exagen Inc. stock outlook for YEARMarket Sentiment Review & Safe Capital Allocation Plans - Newser
How to use Fibonacci retracement on Exagen Inc.July 2025 Retail & Daily Chart Pattern Signals - Newser
Applying chart zones and confluence areas to Exagen Inc.Weekly Earnings Recap & Real-Time Volume Trigger Notifications - Newser
What recovery options are there for Exagen Inc.2025 Big Picture & High Conviction Buy Zone Picks - Newser
Exagen Inc. Stock Lags Behind Sector BenchmarksWeekly Risk Report & Consistent Profit Trading Strategies - 선데이타임즈
Comparing Exagen Inc. in custom built stock radarsCEO Change & Smart Swing Trading Alerts - Newser
Sector ETF Data Correlates with Strength in Exagen Inc.Quarterly Performance Summary & Weekly Setup with High ROI Potential - sundaytimes.kr
What to expect from Exagen Inc. in the next 30 daysGDP Growth & Weekly Market Pulse Alerts - Newser
Key metrics from Exagen Inc.’s quarterly dataMarket Performance Recap & Growth Focused Stock Pick Reports - Newser
Applying Elliott Wave Theory to Exagen Inc.Weekly Stock Recap & Expert Verified Stock Movement Alerts - Newser
What’s next for Exagen Inc. stock priceTrade Signal Summary & Safe Capital Allocation Plans - Newser
What candlestick patterns are forming on Exagen Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - Newser
What makes Exagen Inc. stock price move sharplyFree Entry Zone Strategy for Consistent Profit - Newser
Price action breakdown for Exagen Inc.Smart Forecast Signals from AI Models - Newser
Applying big data sentiment scoring on Exagen Inc.Swing Candidate List with Trade Cues - Newser
How to use a screener to detect Exagen Inc. breakoutsWeekly Entry Signal Based Forecast Tool - Newser
Exagen Inc. Recovery Gathers Momentum on Chart SignalsAI Based High Gain Watchlist Scanner Shared - beatles.ru
Is Exagen Inc. reversing from oversold territorySafe Entry Zone Based on Chart Analysis - Newser
Building trade automation scripts for Exagen Inc.Free ROI Boosting Trade Opportunity Calendar - Newser
Exagen Inc. to Participate in Third Quarter Investor Conferences - The Manila Times
Exagen Doubles Down on Investor Outreach: Set for Major Healthcare Conference Circuit - Stock Titan
Exagen Inc.'s (NASDAQ:XGN) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - simplywall.st
What drives Exagen Inc. stock priceFree Stock Market Beginners Guide - Jammu Links News
What are the latest earnings results for Exagen Inc.Discover breakthrough trading strategies - Jammu Links News
Is Exagen Inc. a good long term investmentMaximize your gains with expert trading tips - Jammu Links News
What are Exagen Inc. company’s key revenue driversBreakthrough financial growth - Jammu Links News
What are analysts’ price targets for Exagen Inc. in the next 12 monthsSuperior returns - Jammu Links News
What is the risk reward ratio of investing in Exagen Inc. stockBreakthrough profit margins - Jammu Links News
What catalysts could drive Exagen Inc. stock higher in 2025Build wealth steadily with smart stock selection - Jammu Links News
Is Exagen Inc. a growth stock or a value stockInvest smarter with advanced market data - Jammu Links News
Is Exagen Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News
Is it the right time to buy Exagen Inc. stockRemarkably fast returns - Jammu Links News
What is the dividend policy of Exagen Inc. stockUnmatched profit potential - Jammu Links News
Exagen outlines $65M–$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline - MSN
Exagen Inc Azioni (XGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):